Patents by Inventor Didier Negre

Didier Negre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8338168
    Abstract: The present invention provides improved chimeric glycoproteins (GPs) and improved lentiviral vectors pseudotyped with those glycoproteins. Also provided are methods and compositions for making such glycoproteins and vectors, and improved methods of in vitro and in vivo transduction of cells with such vectors. Improved chimeric GPs encode the extracellular and transmembrane domains of GALV or RD114 GPs fused to the cytoplasmic tail of MLV-A GP. Vectors pseudotyped with these GAL V/TR and RD 114/TR GP chimeras have significantly higher titers than vectors coated with the parental GPs. Additionally, RD114/TR-pseudotyped vectors are efficiently concentrated and are resistant to inactivation induced by the complement of both human and macaque sera. RD114 GP-pseudotyped lentiviral vectors have particular utility for in vivo gene transfer applications.
    Type: Grant
    Filed: April 25, 2003
    Date of Patent: December 25, 2012
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Institut Clayton de la Recherche
    Inventors: Didier Trono, Francois-Loic Cosset, Virginie Sandrin, Bertrand Boson, Didier Negre, Patrick Salmon
  • Publication number: 20060257366
    Abstract: The present invention provides improved chimeric glycoproteins (GPs) and improved lentiviral vectors pseudotyped with those glycoproteins. Also provided are methods and compositions for making such glycoproteins and vectors, and improved methods of in vitro and in vivo transduction of cells with such vectors. Improved chimeric GPs encode the extracellular and transmembrane domains of GALV or RD114 GPs fused to the cytoplasmic tail of MLV-A GP. Vectors pseudotyped with these GAL V/TR and RD 114/TR GP chimeras have significantly higher titers than vectors coated with the parental GPs. Additionally, RD114/TR-pseudotyped vectors are efficiently concentrated and are resistant to inactivation induced by the complement of both human and macaque sera. RD114 GP-pseudotyped lentiviral vectors have particular utility for in vivo gene transfer applications.
    Type: Application
    Filed: April 25, 2003
    Publication date: November 16, 2006
    Inventors: Didier Trono, Francois-Loic Cosset, Virginie Sandrin, Didier Negre, Patrick Salmon
  • Patent number: 4688443
    Abstract: In a device for controlling elements of a machine, comprising two control members of the joy stick type from one or other of which said elements may be controlled, these members being intended to be actuated by separate operators and each being mounted for tilting about at least one axis and connected to at least one sensor delivering an electric signal representative of the amplitude of tilt of the associated joy stick about said axis on each side of a neutral position, a signal processing system is provided receiving the signals from two sensors and delivering a single control reference addressed to said controlled elements of the machine.
    Type: Grant
    Filed: May 1, 1986
    Date of Patent: August 25, 1987
    Assignee: Aerospatiale Societe Nationale Industrielle
    Inventors: Pierre Fabre, Didier Negre